Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Barry Rosenstein’s JANA Partners Added These Five Stocks to Its Portfolio in Q2

Page 1 of 2

Barry Rosenstein‘s JANA Partners is going through a rough period marked by its worst performance since it was launched in 2001. JANA’s main fund has posted negative returns for 12 out of the last 19 months and has not only underperformed the S&P 500, but also many of its peers. The fund currently has an equity portfolio worth $5.85 billion as of the end of June, slightly higher compared to $5.27 billion reported a year earlier.

In this article, let’s take look at the five new positions, which JANA Partners added to its equity portfolio during the second quarter, and which include Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE), Expedia Inc (NASDAQ:EXPE), Harris Corporation (NYSE:HRS), Pinnacle Foods Inc (NYSE:PF), and Willis Towers Watson PLC (NASDAQ:WLTW).

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see more details here).

Barry Rosenstein - Jana Partners

Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE)

– Shares Owned by Jana Partners (as of June 30): 8.18 million

– Value of Jana Partners holding (as of June 30): $292.11 million

JANA added Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE) to its equity portfolio during the second quarter, having bought 8.18 million shares worth $292.11 million. Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE) is one of the few consumer-related stock covered by Susquehanna, which considers that Coca-Cola European Partners, along with Sodastream International Ltd (NASDAQ:SODA) and Mondelez International Inc (NASDAQ:MDLZ), has the biggest downside risk from exposure to the Euro and the British Pound. Susquehanna also stated that currency risk makes Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE) an unattractive bet compared to Mondelez. A total of 40 funds in our database held long positions in Coca-Cola European Partners plc Ordinary Shares (NYSE:CCE) worth $1.55 billion in aggregate, during the second quarter.

Follow Coca Cola Enterprises Inc (NYSE:CCE)
Trade (NYSE:CCE) Now!

Expedia Inc (NASDAQ:EXPE)

– Shares Owned by Jana Partners (as of June 30): 2.07 million

– Value of Jana Partners holding (as of June 30): $219.96 million

In Expedia Inc (NASDAQ:EXPE), the fund acquired 2.07 million shares worth $219.96 million during second quarter. Shares of Expedia Inc (NASDAQ:EXPE) are down by 13.04% since the beginning of the year. For the second quarter, Expedia Inc (NASDAQ:EXPE) reported revenue of around $2.2 billion, which was $50 million lower than expected, while EPS of $0.83 topped the consensus estimate of $0.78. Out of the total funds tracked by our team, 67 funds held long positions in Expedia with total value of $3.87 billion at the end of June.

Follow Expedia Inc. (NASDAQ:EXPE)
Trade (NASDAQ:EXPE) Now!

On the next page, we will look at Harris Corporation (NYSE:HRS), Pinnacle Foods Inc (NYSE:PF), and Willis Towers Watson PLC (NASDAQ:WLTW).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!